AbbVie Asks Fed. Cir. To Revive Antibody Patent Suit

AbbVie Asks Fed. Cir. To Revive Antibody Patent Suit

AbbVie Deutschland GmbH & Co. on Monday asked the Federal Circuit to reverse a jury’s decision invalidating as obvious a pair of patents covering genetically engineered human antibodies to interleukin 12, a protein whose overproduction is associated ...read more

  • Tags: